-
Economic Impact of Trastuzumab and Its Biosimilars for the Treatment of HER2-Positive Breast Cancer Patients: A Real-World Study in the US
Mar 10, 2025, 14:00 PM -
Disparities in Breast Cancer Screening Rates are Compounded by Type of Insurance Coverage and Social Drivers of Health
Mar 10, 2025, 14:00 PM -
Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in the Front-Line Maintenance Setting for Advanced Ovarian Cancer (OC): A Trial-Level Meta-Analysis
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Adults 60 Years of Age and Older in Japan
Mar 10, 2025, 14:00 PM -
A Real-World Retrospective Cohort Study Characterizing Patients with MMN in the United States
Mar 10, 2025, 14:00 PM -
Treatment Patterns and Healthcare Resource Utilization in Patients Diagnosed With CRSwNP in HMO From Colombia: A Real Word Evidence Study
Mar 10, 2025, 14:00 PM -
Economic Evaluations of Imaging Guidance for Percutaneous Coronary Interventions: A Scoping Review
Mar 10, 2025, 14:00 PM -
Assessing the Comorbidity Burden of Ehlers-Danlos Syndromes (EDS): An Analysis Using US Real-World Data
Mar 10, 2025, 14:00 PM -
Evaluation of Measurement Properties of Health Assessment Questionnaire Disability Index (HAQ-DI) among Gout Populations in China
Mar 10, 2025, 14:00 PM -
Could Offering Physiotherapy Services in Emergency Departments Improve Patients’ Quality of Life While Reducing Healthcare Costs?
Mar 10, 2025, 14:00 PM -
Characterizing the Experience of Excessive Daytime Sleepiness in Patients with Idiopathic Hypersomnia: Implications for Measuring Daytime Sleepiness with the Epworth Sleepiness Scale in a Clinical Trial (NCT05156047)
Mar 10, 2025, 14:00 PM -
Sizing Up the Gap: Evaluating Sample Size Justification in Prospective Real-World Studies
Mar 10, 2025, 14:00 PM -
Reporting Standards in Predictive Modeling of Cancer Outcomes: An Umbrella Review of Adherence to the TRIPOD SR MA Reporting Guideline
Mar 10, 2025, 14:00 PM -
Prospective, Comparative Study Between Fully-Automated and Semi-Automated Whole Blood Processing Systems in a Colombian Blood Bank Center
Mar 10, 2025, 14:00 PM -
Inclusion of Health-Related Quality of Life (HRQoL) and Other Patient-Reported Outcomes (PROs) in the United States Food and Drug Administration (FDA) Labels
Mar 10, 2025, 14:00 PM -
Assessability of Single-Arm Studies (SAT) Under Joint Clinical Assessment (JCA): Whether Drugs Assessed With SAT in the Last Years Would Fit Under the New EU HTA Framework?
Mar 10, 2025, 14:00 PM -
Pre-Diagnostic Healthcare for People with Fragile X Syndrome
Mar 10, 2025, 14:00 PM -
Trends and Disparities in Weight Loss Activities Among Adults With Prediabetes and Obesity in the United States: 2009-2020
Mar 10, 2025, 14:00 PM -
Guidance for the Role of Key Opinion Leaders in the Identification and Validation of Treatment Effect Modifiers and Prognostic Variables in Indirect Treatment Comparisons
Mar 10, 2025, 14:00 PM -
Patient and Diagnostic Delay in Patients With Breast or Colorectal Cancer
Mar 10, 2025, 14:00 PM